Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
Analysis of cellular function of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
批准号:
10671308
负责人:
ARAKI Norie
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The neurofibromatosis type 2 (NF2) is an autosomal dominantly inherited disorder, and strongly associated with development of benign intracranial tumors including bilateral vestibular schwannomas and meningiomas. NF2 gene was recently cloned, and the protein it encodes (termed as merlin/schwannomin) was found to be striking similarity to the moesin-ezrin-radixin (MER) family of cytoskeleton-associated proteins. To elucidate the biological function of NF2 protein (merlin), we analyzed the mutation pattern of merlin, its cellular localization, and the cellular signals via merlin. 1) NF2 gene mutations in NF2 patients were analyzed by protein truncation test. The majority of NF2 mutations are nonsense, frame shift, or exon-missing mutations. More than 70%of the mutations are clustered in the region encoding the N-terminal half of merlin. In addition, post-transrational proteolytic cleavage of N-terminal merlin by the ubiquitous protease calpain was found in some schwannomas and meningioma … More s. These results suggest that the N-terminal region of merlin is the most important for the tumor suppressive function, 2) Cellular expression systems of mutants or wild NF2 were established, and their cellular localization was analyzed by confocal lazer scanning Microscopy (CLSM). The wild merlin showed cytoplasmic and submembranous localization that was found to be directed by its nuclear export signal (NES) dependent transport mechanism. The N-terminal mutation resulted in nuclear accumulation of merlin. 3) Cellular binding proteins of merlin were purified from bovine brain extracts and identified as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70 by the analysis of their internal amino-acid sequences. The N-terminal(19-339) region of merlin is essential for their interaction. The immuno-precipitation, western blotting, and CLMS study confirmed their cellular co-localization. NF2 mutations impair the merlin-related complex formation and their cellular signal transport. This loss of cellular function of merlin may link to the intracranial tumor generation. Less
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kuwahara H, Araki N, Makino K, Masuko N, Honda S, Kaibuchi K, Fukunaga K Miyamoto E, Ogawa M, and Saya H: "A novel NE-dlg/SAP102-associated protein, p51-nedasin, related to the aminohydrolyse superfamily, interferes with the association between NE-dlg/SAP
Kuwahara H、Araki N、Makino K、Masuko N、Honda S、Kaibuchi K、Fukunaga K Miyamoto E、Okawa M 和 Saya H:“一种新型 NE-dlg/SAP102 相关蛋白 p51-nedasin,与氨基水解有关
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
masuko N, et al.: "Interaction of NE-dlg/SAP102, a neuron and endocrine tissue-specific membrane-associated guanylate kinase protein, with calmodulin and PSD-95/SAP90. A possible reguulatory role in molecular clustering at synaptic sites"J. Biol. Chem.. 2
Masuko N 等人:“NE-dlg/SAP102(一种神经元和内分泌组织特异性膜相关鸟苷酸激酶蛋白)与钙调蛋白和 PSD-95/SAP90 的相互作用。突触位点分子聚集中可能的调节作用”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N.,Saya,H.: "Cellular signal transduction via the neurofibromatosis type 2 tumor supressor gene product;Merlin."Seikagaku. 71(2). 43-49 (1999)
Araki,N.,Saya,H.:“通过神经纤维瘤病 2 型肿瘤抑制基因产物进行细胞信号转导;Merlin。”Seikagaku。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Araki,N.: "Cellular signal transduction via the neurofibromatosis type 2 tumor supressor gene product;Merlin." Seikagaku. 71(2). 43-49 (1999)
Araki,N.:“通过神经纤维瘤病 2 型肿瘤抑制基因产物进行细胞信号转导;Merlin。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shibayama R. et al.: "Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction"Diabetes.. 48(9). 1842-1849 (1999)
Shibayama R.等人:“针对N(ε)-(羧甲基)赖氨酸的自身抗体:美拉德反应的高级糖基化终产物”糖尿病.. 48(9)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Analysis of molecular network on maintenance and differentiation of glioma stem cells
-
批准号:25640068
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:ARAKI Norie
-
依托单位:
System development for microquantitative molecular analyses ofglioma stem cells
-
批准号:23659693
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:ARAKI Norie
-
依托单位:
Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
-
批准号:22390281
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:ARAKI Norie
-
依托单位:
Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
-
批准号:19390382
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:ARAKI Norie
-
依托单位:
Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
-
批准号:16390413
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.77万
-
财政年份:2004
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products
-
批准号:14571319
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:ARAKI Norie
-
依托单位:
Study on cellular signal transduction of Neurofibromatosis Type 2 tumor suppressor gene product (Merlin)
-
批准号:12671369
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:ARAKI Norie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LPS调控TFAM/NF2介导睾丸间质细胞铁死亡抑制雄激素合成的机制研究
-
批准号:QN25H040004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈显武
-
依托单位:
基质硬度微环境中 UBXN1 通过调控 NF2 泛素
化激活 YAP/TAZ 通路促进 HCC 生长转移
-
批准号:Y24H160144
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:窦常伟
-
依托单位:
抑癌基因NF2调控恶性胸膜间皮瘤核苷酸代谢的分子机制及靶向干预
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:许多
-
依托单位:
祛毒散结方通过改善肿瘤乏氧微环境抑制肿瘤相关巨噬细胞功能在NF2脑膜瘤治疗中的作用及机制研究
-
批准号:82304952
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李仕维
-
依托单位:
NF2/merlin与DCAF1 E3泛素连接酶互作介导肿瘤抑制的机理探索
-
批准号:82360610
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:崔岩
-
依托单位:
放射治疗NF2相关前庭神经鞘膜瘤诱发听觉神经元焦亡导致听力损伤的机制研究
-
批准号:82303686
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙瑶
-
依托单位:
MYC超级增强子激活促进NF2突变型脑膜瘤复发及进展的分子机制研究
-
批准号:82372752
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:宫晔
-
依托单位:
神经纤维瘤病2型NF2基因治疗安全性及有效性研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:薛璐
-
依托单位:
NF2及其磷酸化修饰通路在生理及病理性血管新生中的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王瑜
-
依托单位:
NF2基因改变通过SOX9介导的细胞周期调控参与肾癌演进的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:梁嘉宇
-
依托单位: